SODASTREAM WILL PAY $10,000 FOR THE MOST UNHINGED SPARKLING DRINK RECIPE
The "Made by Me" Campaign Invites Anyone in the
The initiative is part of Sodastream's Made by Me campaign, which celebrates creativity, self-expression, and personalization in sparkling drink creation. The campaign draws inspiration from the growing "unhinged" trend on social media, where unexpected and unconventional content - from flavor experiments to confessional storytelling - continues to captivate audiences for its authenticity and relatability. With #unhinged used across 253k posts on TikTok alone.
"Sodastream is about empowering people to personalize every part of their drink - from the fizz to the flavor to the vessel it's served in," said
To bring the creativity to real life, Sodastream is also hitting the road with a three-city pop-up tour, stopping in
Whether created at home or at a pop-up, each idea is a reflection of how far imagination can go when personalization is the starting point. With Sodastream, there are no limits - only endless possibilities.
*Terms and conditions apply. See the official rules here.
About Sodastream
Sodastream, a PepsiCo subsidiary, is a top global sparkling water maker brand. Sodastream empowers consumers to create perfect personalized sparkling beverage experiences with just a push of a button. By allowing its users to make better choices for themselves and the planet – Sodastream is revolutionizing the beverage industry and changing the way the world drinks. To learn more about Sodastream visit corp.sodastream.com and follow Sodastream on Instagram, TikTok, Facebook, and YouTube.
Contact:
Alison Brod Marketing + Communications
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/sodastream-will-pay-10-000-for-the-most-unhinged-sparkling-drink-recipe-302518905.html
SOURCE Sodastream
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Apex Institute Reveals What Hiring Managers Actually Want in Cloud and AI Infrastructure Roles
- Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
- 2026’s Top Window Covering Trends, and the Sister-Owned Store Carrying Them All
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share